CID 137379043

Mezigdomide

Structural Information

Molecular Formula
C32H30FN5O4
SMILES
C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCN(CC5)C6=C(C=C(C=C6)C#N)F
InChI
InChI=1S/C32H30FN5O4/c33-26-16-23(17-34)8-9-27(26)37-14-12-36(13-15-37)18-21-4-6-22(7-5-21)20-42-29-3-1-2-24-25(29)19-38(32(24)41)28-10-11-30(39)35-31(28)40/h1-9,16,28H,10-15,18-20H2,(H,35,39,40)/t28-/m0/s1
InChIKey
YTINZZFBHWSAGL-NDEPHWFRSA-N
Compound name
4-[4-[[4-[[2-[(3S)-2,6-dioxopiperidin-3-yl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]piperazin-1-yl]-3-fluorobenzonitrile
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

1
References

519
Patents

567.2282 Da
Monoisotopic Mass

2.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 568.23548 244.9
[M+Na]+ 590.21742 256.9
[M+NH4]+ 585.26202 245.2
[M+K]+ 606.19136 246.7
[M-H]- 566.22092 242.0
[M+Na-2H]- 588.20287 245.8
[M]+ 567.22765 244.7
[M]- 567.22875 244.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe